Evidence map›Paper›PMID 37376051›Full record

ArticlePharmaceutics2023

Eudragit

Emilie Tabare, Tiffany Dauchot, Christel Cochez, Tea Glonti, Céline Antoine, Fanny Laforêt, Jean-Paul Pirnay, Véronique Delcenserie, Damien Thiry, Jonathan Goole

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Pharmacology of Bacteriophage Therapy in Children: A Re-Emerging Paradigm in Antibacterial Therapy.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Simulator of the Human Intestinal Microbial Ecosystem (SHIMEPharmaceuticals (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Bacteriophage therapy for drug-resistantFrontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Emilie TabareLaboratory of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles, 1050 Brussel, Belgium.ORCID 0000-0003-0633-1436
Tiffany DauchotLaboratory of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles, 1050 Brussel, Belgium.
Christel CochezLaboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.
Tea GlontiLaboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.ORCID 0000-0001-5814-3563
Céline AntoineFood Science Department, FARAH and Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium.
Fanny LaforêtFood Science Department, FARAH and Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-0088-4307
Jean-Paul PirnayLaboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium.ORCID 0000-0002-6863-5219
Véronique DelcenserieFood Science Department, FARAH and Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium.
Damien ThiryBacteriology, Department of Infectious and Parasitic Diseases, FARAH and Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-5161-7364
Jonathan GooleLaboratory of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Université Libre de Bruxelles, 1050 Brussel, Belgium.
University of Liège · BEQueen Astrid Military Hospital · BEUniversité Libre de Bruxelles · BE

Funding

This research was funded by the Walloon Public Service, BIOWIN project: Inteliphages. 8060
6 · The paper itself

Abstract

Phage therapy is recognized to be a promising alternative to fight antibiotic-resistant infections. In the quest for oral dosage forms containing bacteriophages, the utilization of colonic-release Eudragit

Indexed as

bacteriophagecapsulescolon-targetingEudragit® FSphage-therapyspray-dryingtablets

Identifiers

PMID37376051
PMCPMC10305712
OpenAlexW4378529008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.